We demonstrate that CypA is overexpressed in chemotherapy‐resistant NSCLC and drives therapeutic evasion by competitively binding to the K37 site of SLC7A11, thereby blocking TRIM3‐mediated K11‐linked ubiquitination and proteasomal degradation of this critical ferroptosis regulator. This evidence concerns the gene TRIM3 and non-small cell lung carcinoma.